Shares of the Puxin Limited (NEW) stock were gloomy in the current market trading session today on December 30, 2021. NEW stock price saw a downtrend of 24.35% to drop at $0.40 a share at the time of this writing. The trading volume was 4,008,018, lower than the average trading volume on the last check. […]
Puxin Limited (NEW) stock is gloomy today: Why is it so? Read More »
Shares of the Future FinTech Group Inc. (FTFT) stock were rising in the current market today on December 30, 2021. FTFT stock price saw an uptrend of 19.67% to reach $1.47 a share at the time of this writing. The stock was gloomy in the previous trading session and went down by 12.77% at closing.
Why is Future FinTech Group Inc. (FTFT) stock rising today? Read More »
Shares of the Aridis Pharmaceuticals, Inc. (ARDS) stock were rising in the premarket trading session today on December 30, 2021. ARDS stock price saw a push of 6.93% to reach $2.16 a share at the time of this writing. The stock was gloomy in the previous trading session and went down by 7.76% at closing.
Aridis Pharmaceuticals, Inc. (ARDS) stock rises in premarket: Here’s Why Read More »
WISekey International Holding AG (WKEY) is one of the leading international cybersecurity company. The company functions through two portions Internet of Things (IoT) and mPKI. Company’s microprocessors protect the pervasive computing influencing the current IoT. The cryptographic Root of Trust (RoT) operates protected verification and identification, in virtual and physical environments for IoT, Blockchain, and
WISekey International Holding AG (WKEY) Stock Rise in Premarket. Here’s why Read More »
On December 30, FSD Pharma Inc. (HUGE) announced a share repurchase program in order to return value to its shareholders. Consequently, the stock was trading at $1.02 apiece with a 3.78% gain premarket, at the last check. In the previous trading session, the HUGE stock barely remained in the green with a slight gain of
Share Repurchase Program: FSD Pharma Inc. (HUGE) stock Hikes Premarket Read More »
Salarius Pharmaceuticals, Inc. (SLRX) stock rebounded in the after-hours on the news of dosing milestone achievement in its ongoing trial. On December 29, the company announced achieving doing milestone in its Phase ½ Sarcoma Trial. During the regular session, the stock was in the red with a loss of 6.19% at its closing price of
Takung Art Co. Ltd. (TKAT) stock rallied big during regular trading on Wednesday like most Chinese penny stocks. After trading heavily at a volume of 28.21 million shares in the session, the stock succumbed to corrections after hours. During the regular session, the stock traded between a low of $3.97 and a high of $5.49.
NovaBay Pharmaceuticals, Inc. (NBY) stock gained a further 6.29% in the after-hours on December 29. The stock has been bullish with no new announcement from the company while it announced a special meeting of stockholders on December 21. During the normal trading session, the stock fluctuated between a high of $0.45 and a low of
NovaBay Pharmaceuticals, Inc. (NBY) stock Advances Further After Hours. Why? Read More »
Pop Culture Group Co. Ltd. (CPOP) stock plunged down in the after-hours due to corrections as the stock gained big in regular session. No new developments or news caused the spike in the stock during the regular session. In regular trading, CPOP stock saw a huge increase of 41.13% on no apparent news with 139.43M
Stock Corrections: Pop Culture Group Co. Ltd. (CPOP) stock Plunges After hours Read More »
BiondVax Pharmaceuticals Ltd. (BVXV) shares entered green after the announcement of the successful closing of the $9.8M offering on Wednesday. Previously, the stock was trading in the red, hence, the news caused it to rebound and recover most of its losses of the day. During the regular session, the stock saw a fall of 6.83%
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.